Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway

International Journal of Oncology

Volumn 46, Issue 3, 2015, Pages 1275-1285

  Wu, Yongle ^a   Liu, Hui ^a   Weng, Honglei ^b   Zhang, Xin ^a   Li, Peng ^a   Fan, Chun Lei ^a   Li, Bing ^a   Dong, Pei Ling ^a   Li, Lei ^a   Dooley, Steven ^b   Ding, Hui Guo ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Epithelial mesenchymal transition; Extracellular signal regulated kinase; Glypican 3; Hepatocellular carcinoma; Invasion; Metastasis

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; GELATINASE B; GLYPICAN 3; HEPATITIS B SURFACE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; GLYPICAN; GPC3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; COMPARATIVE STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HEPG2 CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER METASTASIS; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL TIME; TUMOR INVASION; VASCULAR TUMOR; WESTERN BLOTTING; DISEASE COURSE; GENETICS; LIVER TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE; YOUNG ADULT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GLYPICANS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 84921928010     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.2827     Document Type: Article

References (37)

1. He J, Gu D, Wu X, et al: Major causes of death among men and women in China. N Engl J Med 353: 1124-1134, 2005.
2. Farazi PA and DePinho RA: Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6: 674-687, 2006.
3. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558, 2005.
4. Kreuger J, Perez L, Giraldez AJ and Cohen SM: Opposing activities of Dally-like glypican at high and low levels of Wingless morphogen activity. Dev Cell 7: 503-512, 2004.
5. Filmus J, Capurro M and Rast J: Glypicans. Genome Biol 9: 224, 2008.
6. Capurro MI, Xiang YY, Lobe C and Filmus J: Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res 65: 6245-6254, 2005.
7. Stigliano I, Puricelli L, Filmus J, Sogayar MC, Bal de Kier Joffe E and Peters MG: Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation. Breast Cancer Res Treat 114: 251-262, 2009.
8. Peters MG, Farias E, Colombo L, Filmus J, Puricelli L and Bal de Kier Joffe E: Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model. Breast Cancer Res Treat 80: 221-232, 2003.
9. Aviel-Ronen S, Lau SK, Pintilie M, et al: Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma. Mod Pathol 21: 817-825, 2008.
10. Capurro M, Wanless IR, Sherman M, et al: Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 125: 89-97, 2003.
11. Filmus J and Capurro M: Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma. Mol Diagn 8: 207-212, 2004.
12. Liu H, Li P, Zhai Y, et al: Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma. World J Gastroenterol 16: 4410-4415, 2010.
13. Li B, Liu H, Shang HW, Li P, Li N and Ding HG: Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients. Afr Health Sci 13: 703-709, 2013.
14. Llovet JM, Chen Y, Wurmbach E, et al: A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 131: 1758-1767, 2006.
15. Wang XY, Degos F, Dubois S, et al: Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. Hum Pathol 37: 1435-1441, 2006.
16. Miao HL, Pan ZJ, Lei CJ, et al: Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down-regulation of YAP. J Cell Biochem 114: 625-631, 2013.
17. Zittermann SI, Capurro MI, Shi W and Filmus J: Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo. Int J Cancer 126: 1291-1301, 2010.
18. Bruix J, Sherman M and Practice Guidelines Committee AAftSoLD: Management of hepatocellular carcinoma. Hepatology 42: 1208-1236, 2005.
19. Wu YL, Wang NN, Gu L, Yang HM, Xia N and Zhang H: The suppressive effect of metabotropic glutamate receptor 5 (mGlu5) inhibition on hepatocarcinogenesis. Biochimie 94: 2366-2375, 2012.
20. Vauthey JN, Lauwers GY, Esnaola NF, et al: Simplified staging for hepatocellular carcinoma. J Clin Oncol 20: 1527-1536, 2002.
21. Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890, 2009.
22. Ding W, You H, Dang H, et al: Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology 52: 945-953, 2010.
23. Zhang W, Mendoza MC, Pei X, et al: Down-regulation of CMTM8 induces epithelial-to-mesenchymal transition-like changes via c-MET/extracellular signal-regulated kinase (ERK) signaling. J Biol Chem 287: 11850-11858, 2012.
24. Chen X, Lingala S, Khoobyari S, Nolta J, Zern MA and Wu J: Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations. J Hepatol 55: 838-845, 2011.
25. Sun CK, Chua MS, He J and So SK: Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-beta2. Neoplasia 13: 735-747, 2011.
26. Cheng W, Tseng CJ, Lin TT, et al: Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway. Carcinogenesis 29: 1319-1326, 2008.
27. Pan Z, Chen C, Long H, et al: Overexpression of GPC3 inhibits hepatocellular carcinoma cell proliferation and invasion through induction of apoptosis. Mol Med Rep 7: 969-974, 2013.
28. Sung YK, Hwang SY, Farooq M, Kim JC and Kim MK: Growth promotion of HepG2 hepatoma cells by antisense-mediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling. Exp Mol Med 35: 257-262, 2003.
29. Lin CW, Mars WM, Paranjpe S, et al : Hepatocyte proliferation and hepatomegaly induced by phenobarbital and 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene is suppressed in hepatocyte-targeted glypican 3 transgenic mice. Hepatology 54: 620-630, 2011.
30. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119: 1438-1449, 2009.
31. Thiery JP and Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142, 2006.
32. Zhu M, Yin F, Fan X, et al: Decreased TIP30 promotes Snail-mediated epithelial-mesenchymal transition and tumor-initiating properties in hepatocellular carcinoma. Oncogene: Mar 31, 2014 (Epub ahead of print). doi: 10.1038/onc.2014.73.
33. Cho NH, Shim HS, Rha SY, et al: Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma. Eur Urol 44: 560-566, 2003.
34. Li H, Wang H, Wang F, Gu Q and Xu X: Snail involves in the transforming growth factor beta1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cells. PLoS One 6: e23322, 2011.
35. Suh Y, Yoon CH, Kim RK, et al: Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells. Oncogene 32: 4873-4882, 2013.
36. Huang XY, Ke AW, Shi GM, et al: alphaB-crystallin complexes with 14-3-3zeta to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma. Hepatology 57: 2235-2247, 2013.
37. Yoshida S, Kornek M, Ikenaga N, et al: Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma. Hepatology 58: 1667-1680, 2013.